Drug intelligence / Profile preview

Qingyan Lihou Decoction

Development stage: Phase 2
Lead developer: Inner Mongolia Minzu University College of Mongolian Medicine
Administration: Oral

Overview

Qingyan Lihou Decoction is a Traditional Chinese Medicine (TCM) herbal formula investigated for the treatment of chronic pharyngolaryngitis. The formula typically comprises a combination of medicinal herbs, including *Scrophulariae Radix* (Xu Shen), *Ophiopogonis Radix* (Mai Dong), *Platycodonis Radix* (Jie Geng), and *Glycyrrhizae Radix* (Gan Cao), among others. It is designed to "clear heat," "detoxify," and "moisten the throat" according to TCM principles. Clinically, it is evaluated for its efficacy in reducing symptoms such as throat congestion, pain, and the sensation of a foreign body, likely through multi-target anti-inflammatory and mucosal-protective effects on the pharyngeal mucosa.

Other names: Qingyan Lihou TangQingyan Lihou Formula

Beyond the preview

Go deeper on Qingyan Lihou Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingyan Lihou Decoction.

Explore the full profile